Related Experiment Video
Updated: May 30, 2026
10:37
Ferric Chloride-induced Murine Thrombosis Models
Published on: September 5, 2016
Sex differences in antiplatelet response in ischemic stroke.
Dawn M Meyer1, Jo-Ann Eastwood, Margaret P Compton
1Stroke Center & Department of Neurosciences, University of California at San Diego, 200 W Arbor Drive, MON, Suite 3, San Diego, CA 92103-8466, USA. dmmeyer@ucsd.edu
Women'S Health (London, England)
|July 28, 2011
Summary
Women experience more ischemic strokes and have poorer recovery than men. Understanding sex-specific antiplatelet drug responses is crucial for improving stroke outcomes in women.
Area of Science:
- Neurology
- Cardiovascular Medicine
- Pharmacology
Background:
- Ischemic stroke occurrence, treatment, and outcomes exhibit significant sex disparities.
- Women experience more stroke events and have less favorable recovery compared to men.
- Projected increases in stroke incidence and mortality among women underscore the need for sex-specific research.
Purpose of the Study:
- To explore sex differences in antiplatelet treatment response in ischemic stroke.
- To examine the role of estrogen in mediating these sex-specific responses.
- To provide a conceptual framework for understanding these disparities in clinical practice.
Main Methods:
- Review of emerging evidence on sex differences in stroke.
- Analysis of interactions between estrogen, antiplatelet drugs, and stroke outcomes.
- Examination of clinical trial data regarding sex-specific antiplatelet treatment response.
Main Results:
- Antiplatelet therapy may offer stroke protection but not myocardial infarction prevention in women, with opposite effects in men.
- Estrogen levels may mediate sex differences in antiplatelet treatment efficacy.
- Current understanding and application of antiplatelet treatments in women with ischemic stroke require further investigation.
Conclusions:
- Addressing sex-specific issues in stroke is critical for effective treatment of women.
- Further research is needed to determine optimal antiplatelet medication and dosage for women.
- A comprehensive understanding of sex differences in antiplatelet response is essential for improving secondary stroke prevention in women.
Related Concept Videos
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
01:15Ischemic Stroke l: Introduction
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:15Ischemic Stroke ll: Pathophysiology
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...